{"url_path":"/sec/tcrt/8-k/2026-06-29/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-29","source_url":"https://www.sec.gov/Archives/edgar/data/1107421/0001193125-26-286914-index.html","accession_number":"0001193125-26-286914","cik":"0001107421","ticker":"TCRT","issuer_name":"Alaunos Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1107421/0001193125-26-286914-index.html","primary_entity_key":"0001107421","primary_entity_name":"Alaunos Therapeutics, Inc."},"word_count":80,"has_tables":true,"body_markdown":"Item 9.01 – Financial Statements and Exhibits.\n\n \n\n(d) Exhibits.\n\n \n\nExhibit No.\n\nDescription\n\n99.1\n\n[Press Release, dated June 29, 2026](tcrt-ex99_1.htm)\n\n104\n\nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n \n\nSIGNATURES\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nAlaunos Therapeutics, Inc.\n\n \n\n \n\n \n\nDate:\n\nJune 29, 2026\n\nBy:\n\n/s/ Holger Weis\n\n \n\nName:\n\nHolger Weis\n\n \n\nTitle:\n\nChief Executive Officer"}